跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
陳 怡仁
教授
醫學系婦產學科
電子郵件
chenyj
vghtpe.gov
tw
h-index
h10-index
h5-index
3988
引文
33
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1860
引文
21
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
354
引文
10
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2000
2025
每年研究成果
概覽
指紋
網路
研究成果
(151)
類似的個人檔案
(6)
指紋
查看啟用 Yi-Jen Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Endometriosis
96%
Uterine Cancer
85%
Krukenberg Tumor
79%
Recurrent Disease
79%
Retrospective Cohort Study
72%
Systematic Review
70%
Uterine Myomectomy
67%
Myoma
66%
Overall Survival
65%
Adenomyosis
63%
Neoplasm
62%
Ovarian Cancer
60%
Cervical Cancer
54%
Cisplatin
49%
Obstetrics
48%
Gynecology
48%
Diseases
44%
Gestational Age
43%
Pelvis
41%
Cystectomy
41%
Laparoscopic Surgery
41%
Pregnancy
40%
Uterus Sarcoma
39%
Induced Pluripotent Stem Cell
39%
Operation Duration
35%
Clear Cell Carcinoma
34%
Cyclooxygenase 2
33%
Progression Free Survival
33%
Cytoreductive Surgery
33%
Cancer
33%
Uterine Fibroid
32%
Angiogenesis
31%
Bleeding
30%
Prognostic Factor
30%
Uterine Tube Carcinoma
29%
Morcellation
29%
Stress Incontinence
29%
Endometrium Carcinoma
29%
Adenocarcinoma
29%
Menorrhagia
29%
Adverse Event
28%
Doppler Ultrasound
27%
Doppler Flowmetry
27%
Recurrence Risk
27%
Dentigerous Cyst
26%
First Trimester Pregnancy
26%
Randomized Controlled Trial
24%
Surgery
23%
Gonadorelin Agonist
23%
Disease Free Survival
22%
Keyphrases
Taiwan
100%
Endometriosis
83%
Induced Pluripotent Stem Cells (iPSCs)
79%
Confidence Interval
64%
Taiwanese
64%
Retrospective Cohort Study
63%
Endometrial Cancer
62%
Adenomyosis
61%
Epithelial Ovarian Cancer
61%
Estrogen
55%
Overall Survival
54%
Myomectomy
41%
Postmenopausal Women
40%
Ovarian Cancer
40%
Single Port
39%
Uterine Sarcoma
39%
Laparoscopic Surgery
39%
Gonadotropin-releasing Hormone
36%
Cervical Cancer
36%
Laparoscopic Myomectomy
35%
Ovarian Cancer Patients
35%
Recurrence Rate
33%
Gestational Age
32%
Cancer Patients
31%
Cisplatin
31%
Angiogenesis
31%
Operative Time
30%
Fallopian Tube Carcinoma
29%
Bipolar Coagulation
29%
Uterine Vessels
29%
Taiwanese Women
29%
Rare Case Report
29%
Endometrial Carcinoma
29%
Laparoscopic Cystectomy
29%
Overexpression
29%
Cyclooxygenase-2
28%
Obstetrics
27%
Advanced Stage
26%
Randomized Controlled Trial
26%
Prognostic Factors
26%
Ovarian Clear Cell Carcinoma
24%
Adverse Events
24%
Power Doppler Ultrasound
24%
Mouse Model
23%
Normal Pregnancy
23%
Agonist Treatment
23%
Hazard Ratio
23%
Transplantation
23%
Levonorgestrel-releasing Intrauterine System (LNG-IUS)
23%
Laparoscopy
22%
